发明授权
- 专利标题： Compound having PD-L1 inhibitory activity, preparation method therefor and use thereof
-
申请号： US16639949申请日： 2018-08-17
-
公开(公告)号： US11787766B2公开(公告)日： 2023-10-17
- 发明人: Lei Jiang , Jianwen Deng , Xiaoli Lu , Ke Shang , Jianyong Shou , Bing Wang , Danyi Wu , Xueli Xu , Yuan Xu , Yi Zhang , Mingwei Zheng
- 申请人： SHANGHAI ENNOVABIO PHARMACEUTICALS CO., LTD.
- 申请人地址： CN Shanghai
- 专利权人： SHANGHAI ENNOVABIO PHARMACEUTICALS CO., LTD.
- 当前专利权人： SHANGHAI ENNOVABIO PHARMACEUTICALS CO., LTD.
- 当前专利权人地址： CN Shanghai
- 代理机构： Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- 优先权： CN 1710712191.8 2017.08.18
- 国际申请： PCT/CN2018/101191 2018.08.17
- 国际公布： WO2019/034172A 2019.02.21
- 进入国家日期： 2020-06-29
- 主分类号： C07D213/69
- IPC分类号： C07D213/69 ; C07D213/73 ; C07D213/84 ; C07D401/14 ; C07D405/14 ; C07D409/14 ; C07D519/00 ; A61K31/137 ; A61K31/165 ; A61K31/4155 ; A61K31/437 ; A61K31/44 ; A61K31/444 ; A61K31/4545 ; A61K39/12 ; A61K39/245 ; A61K39/29 ; A61K45/06 ; C07C211/03 ; C07C223/02 ; C07D231/40
摘要：
Provided are a compound for the prevention and treatment of diseases associated with PD-L1, a preparation method therefor and use thereof. Specifically, provided are the compound of formula I, the stereoisomer and the racemate thereof, or pharmaceutically acceptable salts thereof, and also provided is an application thereof in the preparation of a drug for the prevention and treatment of diseases associated with PD-L1.
信息查询
IPC分类:
